CN105229169A - 用于诊断膀胱癌的非侵入性诊断方法 - Google Patents

用于诊断膀胱癌的非侵入性诊断方法 Download PDF

Info

Publication number
CN105229169A
CN105229169A CN201480011550.1A CN201480011550A CN105229169A CN 105229169 A CN105229169 A CN 105229169A CN 201480011550 A CN201480011550 A CN 201480011550A CN 105229169 A CN105229169 A CN 105229169A
Authority
CN
China
Prior art keywords
gene
genes
igf2
magea3
crh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480011550.1A
Other languages
English (en)
Chinese (zh)
Inventor
安东尼奥·阿尔卡拉斯阿森西奥
洛德斯·门瓜尔布里希斯
玛丽亚·何塞·里巴尔卡帕罗斯
胡安·何塞·洛萨诺萨尔瓦特利亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fina Biotech SL
Original Assignee
Fina Biotech SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fina Biotech SL filed Critical Fina Biotech SL
Publication of CN105229169A publication Critical patent/CN105229169A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/32—Surgical cutting instruments
    • A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
    • A61B2017/00238—Type of minimally invasive operation
    • A61B2017/00278—Transorgan operations, e.g. transgastric
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plasma & Fusion (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201480011550.1A 2013-01-31 2014-01-31 用于诊断膀胱癌的非侵入性诊断方法 Pending CN105229169A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13382030.8 2013-01-31
EP13382030.8A EP2762574A1 (en) 2013-01-31 2013-01-31 Non-invasive diagnostic method for diagnosing bladder cancer
PCT/EP2014/051939 WO2014118334A1 (en) 2013-01-31 2014-01-31 Non-invasive diagnostic method for diagnosing bladder cancer

Publications (1)

Publication Number Publication Date
CN105229169A true CN105229169A (zh) 2016-01-06

Family

ID=47877961

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480011550.1A Pending CN105229169A (zh) 2013-01-31 2014-01-31 用于诊断膀胱癌的非侵入性诊断方法

Country Status (8)

Country Link
US (1) US9902998B2 (enExample)
EP (3) EP2762574A1 (enExample)
JP (1) JP2016507233A (enExample)
CN (1) CN105229169A (enExample)
AU (1) AU2014211392A1 (enExample)
CA (1) CA2900022C (enExample)
IL (1) IL240310A0 (enExample)
WO (1) WO2014118334A1 (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106916887A (zh) * 2017-02-13 2017-07-04 徐州市中心医院 Erh基因在制备膀胱癌诊治产品中的应用
CN107766695A (zh) * 2017-10-20 2018-03-06 中国科学院北京基因组研究所 一种获取外周血基因模型训练数据的方法及装置
CN108866194A (zh) * 2018-08-16 2018-11-23 杭州可帮基因科技有限公司 一组用于膀胱癌检测的基因及其应用
WO2018219342A1 (zh) * 2017-06-01 2018-12-06 立森印迹诊断技术有限公司 一种印记基因分级模型和诊断方法及其应用
WO2018218737A1 (zh) * 2017-06-01 2018-12-06 立森印迹诊断技术（无锡）有限公司 一种印记基因在膀胱肿瘤中的分级模型及其组成的系统
CN111154879A (zh) * 2020-03-06 2020-05-15 北京恩泽康泰生物科技有限公司 用于膀胱癌诊断或复发监控的生物标志物及试剂盒
CN112680522A (zh) * 2021-01-15 2021-04-20 杭州可帮基因科技有限公司 一种检测膀胱癌的试剂盒
CN116024345A (zh) * 2023-01-12 2023-04-28 上海仁度生物科技股份有限公司 膀胱癌的实时荧光核酸恒温扩增检测试剂盒及其专用引物和探针
CN119410773A (zh) * 2024-11-01 2025-02-11 上海爱谱蒂康生物科技有限公司 一种生物标志物组合及其在预测膀胱癌风险中的应用

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
WO2013158972A1 (en) 2012-04-20 2013-10-24 Cepheid Methods of detecting bladder cancer
US10329622B2 (en) 2013-03-06 2019-06-25 Cepheid Methods of detecting bladder cancer
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
CN105368959B (zh) * 2015-12-15 2019-01-04 甘肃中天羊业股份有限公司 Anxa10基因作为绵羊免疫性状的分子标记及其应用
CL2016003434A1 (es) * 2016-12-30 2018-11-23 Pontificia Univ Catolia De Chile Método ex vivo de pronóstico de metástasis en cáncer de próstata
CA3085933A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
EP3781714B1 (en) * 2018-04-14 2026-01-07 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
EP4165416A1 (en) * 2020-06-10 2023-04-19 Board of Regents, The University of Texas System Method for determining risk of pre-term birth
KR102632423B1 (ko) * 2021-02-26 2024-01-31 충북대학교 산학협력단 비근침윤성 방광암의 예후 예측을 위한 바이오마커 및 이의 용도
KR102500377B1 (ko) 2021-05-11 2023-02-16 재단법인 아산사회복지재단 Fos 또는 cdk1 유전자 활성화를 통해 기능 향상된 줄기세포를 이용한 배뇨 장애 질환 치료 용도
CN114240839B (zh) * 2021-11-17 2023-04-07 东莞市人民医院 基于深度学习的膀胱肿瘤肌层侵犯预测方法及相关装置
CN117670883B (zh) * 2024-01-31 2024-05-07 中国医学科学院北京协和医院 一种鉴别高低级别膀胱癌的方法、设备和系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101730848A (zh) * 2007-03-20 2010-06-09 因达斯生物有限公司 膀胱癌诊断和/或预后方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512437A (en) * 1994-03-01 1996-04-30 Ludwig Institute For Cancer Research Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3
ES2323927B1 (es) 2007-03-30 2010-05-14 Laboratorios Salvat, S.A. Metodo in vitro no invasivo para detectar carcinoma transicional de vejiga.
WO2013158972A1 (en) 2012-04-20 2013-10-24 Cepheid Methods of detecting bladder cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101730848A (zh) * 2007-03-20 2010-06-09 因达斯生物有限公司 膀胱癌诊断和/或预后方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JENNY A. WATSON, ET AL.: "Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder", 《BJU INTERNATIONAL》 *
L.MENGUAL等: "Gene expression signature in urine for diagnosing and assessiong aggressiveness of bladder urothelial carcinoma.", 《CLINICIL CANCER RESEARCH》 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106916887A (zh) * 2017-02-13 2017-07-04 徐州市中心医院 Erh基因在制备膀胱癌诊治产品中的应用
WO2018218737A1 (zh) * 2017-06-01 2018-12-06 立森印迹诊断技术（无锡）有限公司 一种印记基因在膀胱肿瘤中的分级模型及其组成的系统
WO2018219342A1 (zh) * 2017-06-01 2018-12-06 立森印迹诊断技术有限公司 一种印记基因分级模型和诊断方法及其应用
CN107766695A (zh) * 2017-10-20 2018-03-06 中国科学院北京基因组研究所 一种获取外周血基因模型训练数据的方法及装置
US11401560B2 (en) 2018-08-16 2022-08-02 Hangzhou Canhelp Genomics Technology Co. Ltd. Set of genes for bladder cancer detection and use thereof
WO2020034583A1 (zh) * 2018-08-16 2020-02-20 杭州可帮基因科技有限公司 一组用于膀胱癌检测的基因及其应用
CN108866194B (zh) * 2018-08-16 2021-03-26 杭州可帮基因科技有限公司 一组用于膀胱癌检测的基因及其应用
CN108866194A (zh) * 2018-08-16 2018-11-23 杭州可帮基因科技有限公司 一组用于膀胱癌检测的基因及其应用
CN111154879A (zh) * 2020-03-06 2020-05-15 北京恩泽康泰生物科技有限公司 用于膀胱癌诊断或复发监控的生物标志物及试剂盒
CN112680522A (zh) * 2021-01-15 2021-04-20 杭州可帮基因科技有限公司 一种检测膀胱癌的试剂盒
CN116024345A (zh) * 2023-01-12 2023-04-28 上海仁度生物科技股份有限公司 膀胱癌的实时荧光核酸恒温扩增检测试剂盒及其专用引物和探针
CN116024345B (zh) * 2023-01-12 2023-12-01 上海仁度生物科技股份有限公司 膀胱癌的实时荧光核酸恒温扩增检测试剂盒及其专用引物和探针
CN119410773A (zh) * 2024-11-01 2025-02-11 上海爱谱蒂康生物科技有限公司 一种生物标志物组合及其在预测膀胱癌风险中的应用
CN119410773B (zh) * 2024-11-01 2025-07-25 上海爱谱蒂康生物科技有限公司 一种生物标志物组合及其在预测膀胱癌风险中的应用

Also Published As

Publication number Publication date
JP2016507233A (ja) 2016-03-10
EP2951315A1 (en) 2015-12-09
EP4060048A2 (en) 2022-09-21
EP2762574A1 (en) 2014-08-06
US9902998B2 (en) 2018-02-27
CA2900022A1 (en) 2014-08-07
AU2014211392A1 (en) 2015-09-17
WO2014118334A1 (en) 2014-08-07
EP4060048A3 (en) 2022-12-21
EP2951315B1 (en) 2022-11-23
IL240310A0 (en) 2015-09-24
US20160017433A1 (en) 2016-01-21
CA2900022C (en) 2024-05-14

Similar Documents

Publication Publication Date Title
CN105229169A (zh) 用于诊断膀胱癌的非侵入性诊断方法
KR101437718B1 (ko) 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
CN103834729B (zh) 肺癌的多基因预后试验
ES2754434T3 (es) Métodos de pronóstico de cáncer de próstata
US8709736B2 (en) Biomarker for Barrett's Oesophagus
TW200949249A (en) Methods, agents and kits for the detection of cancer
CN106893784A (zh) 用于预测肝癌预后的lncRNA标志物
ES2893469T3 (es) Puntuaciones de riesgo basadas en la expresión de la variante 7 de la fosfodiesterasa 4D humana
CN108738329A (zh) 前列腺癌预后方法
US20240076743A1 (en) Method for Predicting and Treating Clinically Significant Prostate Cancer
CN110229899B (zh) 用于结直肠癌早期诊断或预后预测的血浆标记物组合
CN113355415B (zh) 用于食管癌诊断或辅助诊断的检测试剂及试剂盒
US20190360061A1 (en) Methods and kits for identifying pre-cancerous colorectal polyps and colorectal cancer
Meng et al. The expression of long non-coding RNA LINC01279 in gastric adenocarcinoma and its clinical significance
CN114438208A (zh) 通过外泌体miRNA生物标志物进行肺癌诊断的检测试剂盒和方法
CN103911436A (zh) 一种非贲门胃癌早期诊断的血清/血浆miRNA标志物及其应用
CN103773761B (zh) 检测胃癌的血清/血浆微小rna标志物及其应用
JP6103866B2 (ja) 大腸ガン検出方法、診断用キット及びｄｎａチップ
AU2017270496B2 (en) Determination of genetic predisposition to aggressive prostate cancer
ES2399246T3 (es) Predicción del resultado del tratamiento del cáncer de mama
CN116083583A (zh) miRNA-483-5p在制备胰腺癌肝转移诊断试剂盒中的应用
CN110982901A (zh) 用于侵袭性甲状腺乳头状癌诊断的循环环状rna标志物及应用
CN109825596A (zh) 食管癌样本的内参miRNA及其应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160106

WD01 Invention patent application deemed withdrawn after publication